// May 15, 2025 | American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Deep CRISPR Nuclease Portfolio and Multiple Editing Modalities Accelerates Identification of Viable Clinical Candidates